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Abstract: A computational study of the interaction of cardiac troponin I (cTnI) with its specific antibody and of that 
antibody with skeletal troponin I (sTnI), the principal interferon of cTnI, is carried out. Computational and simulation 
tools such as FTSite, FTMap, FTDock and pyDock are used to determine the binding sites of these molecules and 
to study their interactions and molecular docking performance, allowing us to obtain relevant information related 
with the antigen-antibody interaction for each of the targets. In the context of the development of immunosensing 
platforms, this type of computational analysis allows performing a preliminary in-silico affinity study of the available 
bioreceptors for a better selection when moving to the experimental stage, with the subsequent saving in cost and 
time. 
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1. Introduction 
Cardiovascular diseases are the first cause of death worldwide and heart failure is the end stage of almost all 
heart diseases 1. That heart failure is commonly produced by a damage of the heart myofilaments that can lead to 
systolic failure, resulting on a decrease of the blood circulation, not sufficing organism needs. One of the most 
important components of these myofilaments, in terms of its relationship with cardiac damage, is the cardiac troponin 
(cTn). 
With a molecular weight (MW) of approximately 80 kDa, cardiac troponin is a complex composed of three 
protein subunits having a different role in the myocardial contraction 2. Cardiac troponin T (cTnT; MW~37 kDa) is a 
tropomyosin-binding subunit that regulates the interaction of the troponin complex with the thin filaments. Cardiac 
troponin I (cTnI; MW~22 kDa) inhibits the interaction between myosin and actin, responsible of muscle contraction. 
And finally, cardiac troponin C (cTnC; MW~18 kDa) is a Ca2+ binding subunit responsible of regulating the muscle 
contraction depending on the Ca2+ concentration. The binding of Ca2+ to cTnC produces a conformational change that 
reduces the inhibition of cTnI and thus leads to muscle contraction. That conformational change produced by cTnC is 
reversed when Ca2+ levels are restored, thus creating the contraction-relaxation cycle 3. 
When damage of the myofilaments of the cardiac muscle is produced, a breakage of the troponin complex takes 
place, leading to the release of the troponin subunits (cTnT, cTnI and cTnC) to the blood stream. Thereby, the levels 
of these cardiac troponin subunits in blood can be used as an indicator of myocardial damage. Note that clinical normal 
cTnI levels are below 0.11 µg/L, more elevated values are considered for severe cardiovascular disease (CVD) patients 
4. 
However, troponin is also found in the skeletal muscle, where it is also in charge of controlling the muscle 
contraction-relaxation cycle 5. And as for the cTn, skeletal troponin (sTn) subunits (sTnT, sTnI and sTnC) are also 
released to the blood stream when the myofilaments of the skeletal muscle are damaged. Due to the similarity between 
cardiac and skeletal troponin, sTn subunits may interfere in the detection of cTn ones, thus limiting the performance 
of cTn detection-based analysis systems 6. 
Previous works indicate that, from the three cTn subunits, the utility of cTnC for cardiac damage diagnosis is 
limited by the fact that it presents the same structure than sTnC, with the only difference of the number of Ca2+ binding 
sites 7. Regarding TnT and TnI, cTnT presents several specific cardiac isoforms whereas cTnI presents one (in relation 
with skeletal troponin). Thus, their use in cardiac diagnostic and prognostic applications 8. Several comparative studies 
between cTnT cardiac isoforms and cTnI specific cardiac isoform have been carried out, concluding that cTnI exhibits 
a higher specificity and accuracy than cTnT for the diagnosis of acute myocardial infarction at its early stage 9. 
Therefore, cTnI has become the current gold-standard biomarker in clinical diagnosis for the identification of acute 
 
heart failures. However, it may present a high cross reactivity with the sTnI regarding the interaction with cTnI 
antibody. 
Within this context, in this work we report a computational study of the interaction of a cTnI antibody (αcTnI) 
with cTnI and sTnI. This study allows obtaining information about the biochemical interactions between them and to 
computationally compare the binding performance and the selectivity of the αcTnI towards cTnI versus sTnI rather 
than experimentally. This information can be relevant for the development of analysis systems for myocardial failure 
diagnosis based on cTnI detection. First, FTSite and FTMap were used to analyze the structure of the targets (cTnI 
and sTnI) and the antibody binding fragment (Fab). After the consideration of several possible conformations for cTnI 
and sTnI (more than a hundred), their most stable conformations (i.e., with the lowest total energy) were used to 
determine and characterize the binding regions of these molecules. Next, FTDock and pyDock were used to study the 
molecular docking performance of the cTnI-αcTnI and sTnI-αcTnI complexes in order to determine their most stable 
predicted conformations. Energies and interactions of these predicted conformations allowed us to determine the 
affinity for each of these complexes and thus to characterize the selectivity. 
2. Materials and methods 
2.1. Materials 
2.1.1. Molecules structures 
The X-ray structures of the molecules used in the study were obtained from the Research Collaboratory for 
Structural Bioinformatics (RCSB) protein data bank (pdb). The IDs of the sTnI and the αcTnI structures are 1VDI and 
4P48, respectively. For the case of the cTnI, its sequence was extracted from the whole cardiac troponin complex 
provided by RCSB with the ID 4Y99. Before their use, those molecules were purified by removing those atoms not 
corresponding with the molecules of interest from the original pdb files and that might be present in the downloaded 
models (water and ions). 
2.1.2. FTSite and FTMap 
The binding sites of proteins contain the so-called hot spots, specific regions that provide major contributions to 
the binding free energy. These hot spots are constituted by one or several amino acids that are more likely to bind 
small molecule probes and compounds with high affinity, and hence are the prime targets in several fields such as 
immunology or drugs design 10. Experimental techniques to determine these interactions occurring within the binding 
regions, e.g., nuclear magnetic resonance or X-ray crystallography, are highly expensive, time consuming and can be 
limited by the physical constraints of the protein-solvent system 11. Within this context, the use of computational 
methods allows characterizing these binding regions numerically rather than experimentally in order to predict their 
probability of recognition and binding with other molecules 12. 
In order to determine and characterize the binding sites of the cTnI, sTnI and αcTnI molecules, FTSite and 
FTMap computing tools were used. These tools perform a statistical search of the entire molecule surface using a Fast 
Fourier Transform (FFT) based correlation approach in order to determine those regions prickly to bind other probe 
molecules 13. FTSite search is based on the fact that the binding sites of a protein generally include several amino 
acids sequences that are close enough to be reached by a ligand. FTSite characterizes different properties such as 
volume, hydrophobicity, hydrogen bonding, energy potential, solvent accessibility, desolvation energy and residue 
propensity. On the other hand, FTMap identifies and map the potential interactions from the binding sites of the protein 
by analyzing the binding to clusters of 16 organic probes (ethanol, isopropanol, isobutanol, acetone, acetaldehyde, 
dimethyl ether, cyclohexane, ethane, acetonitrile, urea, methylamine, phenol, benzaldehyde, benzene, acetamide and 
N,N-dimethylformamide). FTMap allows representing the obtained energy expression on a grid, which includes 
attractive and repulsive Van der Waals terms, electrostatic interaction energies and desolvation energies based on 
Poisson-Boltzmann calculations, resulting in a very accurate way to identify low-energy spot clusters 14. 
2.1.3. FTDock and pyDock 
Molecular docking is a prediction methodology used to determine the preferred orientation of two molecules 
when bound to each other to form a stable complex. This preferred orientation can be used to predict their binding 
affinity, i.e., the association strength between those two molecules. FTDock and pyDock were used to model the 
biomolecular docking for the cTnI-αcTnI and sTnI-αcTnI complexes. Both computational tools perform a rigid-body 
 
docking of two biomolecules in order to predict their specific binding geometries and their probability/stability given 
by their lowest total energy (Cheng et al., 2007). Predicted docked complexes were outputted in pdb files, which were 
displayed using PyMOL 3D viewer. FTDock and pyDock implement different molecular docking algorithms, what 
was used to confirm that the obtained results were valid. Finally, note that, besides providing the geometric description 
of the docked complex, pyDock also provides the best docking orientations as scored mainly by electrostatics and 
desolvation energy 17.  
2.2. Methods 
The mapping to determine the binding sites was done using FTSite and FTMap, subsequently. Once the binding 
sites and the amino acids comprising them were determined by FTSite, FTMap was used to map cTnI, sTnI and αcTnI 
and determine the interactions of the constitutive amino acids with the test probes. The corresponding pdb files were 
then uploaded to the FTDock server for the corresponding molecular docking calculations. Several conformations 
were generated and the most suitable prediction was chosen for the next steps. In parallel, the same process was done 
using pyDock for a comparative study of the docking results obtained with FTDock. The 100 most suitable 
conformations were generated in pdb files, only considering the most stable one of each complex. The docking results 
obtained using both methodologies showed no difference, thus confirming the correctness of the analysis carried out.  
 
3. Results and discussion 
First, the binding sites on the molecules surfaces were determined for the cTnI, sTnI and αcTnI. Even when the 
structure of a molecule is determined by crystallography in a complex with a ligand, a complete description of its 
binding sites with that ligand cannot be determined experimentally because complex structures may not fully exploit 
the overall properties of the binding site. Moreover, knowledge of the possible binding sites in the structure of a 
molecule also enables us to analyze and classify them through their binding sites profiles. Figure 1 shows the chosen 
binding sites for cTnI, sTnI and αcTnI determined using FTSite. 
     
Figure 1. FTSite results showing the binding sites (colored grids) of (left) cTnI, (center) sTnI and (right) Fab region of 
the αcTnI. The visualization has been done using PyMOL. 






Table 1. Complete description of the amino acids sequences forming the binding sites given by FTSite for cTnI, sTnI 
and Fab region of the αcTnI. 










Met134; Arg137; Ala138; 
Asn139; Leu140; Lys141, 
Gln142; Val143; Lys145; Glu149; 
Glu151; Lys152; Asp153; 
Leu154; Arg155; Asp156; 
Gly158; Asp159; Trp160; 
Arg161; Asn163; Glu165; Ser168; 
Gly169; Met170; Gly172; 
Arg173; Lys74; Phe177 
 
Leu2; Arg25; Tyr26; Tyr27; Asp28; 
Ala44; Pro45; Thr47; Glu51; Lys54; 
Asn58; Asp93; Asp94; Asn95; Asn97; 
Pro98; Thr99, Phe101; Gly102; Leu130; 
Leu132; Gly172; Leu173; Glu174; 
Trp175; Gln180; Gly185; Ala190; 
Ala191; Lys226; Asp227; Ser229; 
Ser230; Asp231; Tyr234; Asp237; 
Ser238; Asp240; Trp242; His244 
Once the binding sites sequences were obtained using FTSite, FTMap was used to determine the number of H-
bond interactions between the amino acids comprising the binding site and the organic probe molecules tested by 
FTMap. Tables 2, 3 and 4 show the H-bond interactions with the probe molecules for cTnI, sTnI and αcTnI, 
respectively. The first column lists the amino acid number within the binding site, the second lists the amino acid 3-
letter code and the third column lists the number of H-bond contacts between the amino acids and the probe molecules. 
Table 2. cTnI H-bond interaction results between the amino acids from the binding site and the probe molecules as 
identified by FTMap. 
cTnI amino acid number Amino acid 3-letter code Number of H-bond contacts 
49; 52; 72; 79; 80; 81; 
82; 83; 84; 93; 99; 100; 
103; 104; 107; 110; 111; 115 
Leu; Leu; Lys; Arg; Ala; Gln; 
Pro; Leu; Glu; Leu; Gln; Leu; 
Arg; Val; Val; Glu; Arg; Glu 
66; 15; 30; 556; 26; 1510; 
174; 119; 918; 490; 26; 761; 
531; 23; 830; 431; 207; 20 
Table 3. sTnI H-bond interaction results between the amino acids from the binding site and the probe molecules as 
identified by FTMap. 
sTnI amino acid number Amino acid 3-letter code Number of H-bond contacts 
134; 137; 138; 139; 140; 141; 
142; 143; 145; 149; 151; 152; 
153; 154; 155; 156; 158; 159; 
160; 161; 163; 165; 168; 169; 
170; 172; 173; 174; 177 
Met; Arg; Ala; Asn; Leu; Lys; 
Gln; Val; Lys; Glu; Glu; Lys; 
Asp; Leu; Arg; Asp; Gly; Asp; 
Trp; Arg; Asn; Glu; Ser; Gly; 
Met; Gly; Arg; Lys; Phe 
102; 1; 5; 6; 13; 133; 
84; 63; 1094; 60; 2014; 11; 
3708; 2; 883; 2; 3; 3; 
135; 165; 5; 738; 1041; 981; 
1020; 3; 618; 76; 243 
Table 4. αcTnI H-bond interaction results between the amino acids from the binding site and the probe molecules as 
identified by FTMap. 
αcTnI amino acid number Amino acid 3-letter code Number of H-bond contacts 
2; 25; 26; 27; 28; 44; 
45; 47; 51; 54; 58; 93; 
94; 95; 97; 98; 99; 101; 
102; 130; 132; 172; 173; 174; 
175; 180; 185; 190; 191; 226; 
227; 229; 230; 231; 234; 237; 
238; 240; 242; 244 
Leu; Arg; Tyr; Tyr; Asp; Ala; 
Pro; Thr; Glu; Lys; Asn; Asp; 
Asp; Asn; Asn; Pro; Thr; Phe; 
Gly; Leu; Leu; Gly; Leu; Glu; 
Trp; Gln; Gly; Ala; Ala; Lys; 
Asp; Ser; Ser; Asp; Tyr; Asp; 
Ser; Asp; Trp; His 
19; 151; 233; 517; 1; 2; 
693; 2676; 233; 11; 369; 7; 
282; 48; 108; 338; 401; 1804; 
171; 43; 215; 33; 646; 39; 
2220; 395; 14; 923; 66; 24; 
6; 1165; 48; 82; 1392; 816; 
727; 1052; 2228; 8 
After the identification and mapping of binding sites and the interactions of their constitutive amino acids 
sequences, the next step is studying the molecular docking performance for the cTnI and sTnI to αcTnI binding. This 
process of docking provides the specific interaction between the proteins and the antibody Fab region taking into 
account spatial distribution, Van der Waals interactions and rotational restrictions, among others. For the docking 
analysis, FTDock and pyDock were used. FTDock generates several output pdb files with docking probabilities 
organized from the highest to the lowest probable one. On the other hand, pyDock generates several pdb files of the 
docked complexes being randomly organized, but results are accompanied by other generated files describing 
 
energies, positions and angles that can be used to organize the predicted complexes. The ranking of molecular docking 
complexes obtained with both methods are the same, thus confirming the docking results. Figure 2 shows the docked 
complexes obtained for cTnI-αcTnI and sTnI-αcTnI. 
 
    
Figure 2. Most probable docked configurations of (left) cTnI-αcTnI and (right) sTnI-αcTnI complexes. Binding zones 
are highlighted with black circles. 
Table 5 shows the identified H-bond interactions for the cTnI-αcTnI and the sTnI-αcTnI complexes obtained 
using FTDock and pyDock. Three H-bonds are predicted for both complexes. However, while these H-bonds are 
formed by three different amino acids for the cTnI-αcTnI complex, for the sTnI-αcTnI complex two of them are 
formed by the same amino acid from the sTnI (Glu149), what is translated into a weaker H-bond than for cTnI-αcTnI. 
This fact determines the higher affinity of αcTnI towards cTnI than for sTnI. 
Table 5. H-bonds for the cTnI-αcTnI and the sTnI-αcTnI complexes identified using FTDock and pyDock. 








Having identified the most stable predicted structures, the formed cTnI-αcTnI and sTnI-αcTnI complexes were 
visualized using PyMOL to depict the specific interactions between the amino acids sequences previously identified 
(see Fig. 3). 
 
 
   
Figure 3. Detailed 3D view of the (left) cTnI-αcTnI and (right) sTnI-αcTnI docked complexes. H-bonds between the 
amino acids from the binding sites are depicted with dashed red lines and highlighted with black circles. 
FTDock provides more than a thousand possible combinations for the two docked troponins to αcTnI. Different 
parallel data were also given to distinguish the most stable configurations as previously mentioned. Table 6 depict the 
parameters describing energies of the most stable docking configurations for the cTnI-αcTnI and sTnI-αcTnI 
complexes. We can see that the total energy of the cTnI-αcTnI complex is considerably lower than for the sTnI-αcTnI 
complex, what indicates a higher affinity of αcTnI towards cTnI than for sTnI. This confirms the lower affinity for 
the sTnI-αcTnI complex predicted from the H-bonds performance previously shown in Table 5 and Fig. 3. 








cTnI-αcTnI -11.866 -20.190 28.475 -29.208 
sTnI-αcTnI -29.635 -3.683 72.809 -26.037 
 
Therefore, this study reveals that the selected αcTnI antibody is suitable for the experimental development of a 
cTnI-selective biosensing system in a subsequent stage. By performing this type of theoretical and computational 
analysis, we are able to preliminary determine the suitability of a certain capture antibody without the need of investing 
a large amount of resources on its experimental selection as well as to obtain more interesting information about it. 
This allows defining a better initial design of our biosensing experiments, with an enormous thrift on cost, effort and 
time. 
4. Conclusions 
 In this work, we have demonstrated that an affinity study can be performed computationally rather than 
experimentally, what can dramatically reduce time and cost when developing immunosensing systems. As far as we 
know, this is the first time that this type of computational affinity study is performed for cardiac troponin I. The 
obtained computational affinity and selectivity results are highly important, since they compare the suitability of cTnI 
and its principal interferon sTnI to bind αcTnI for a cross reactivity study, with the aim of a correct selection of a 
bioreceptor for the development of a cTnI biosensor for an effective, selective, fast and direct early detection of a 
myocardial failure. 
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